(Q42790618)

English

Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity

scientific article published on November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

methicillin-resistant Staphylococcus aureus

0 references

ceftaroline fosamil

1 reference

ChEBI release 2020-05-28

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

George L Drusano

1

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

language of work or name

0 references

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

65 Suppl 4

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

iv33-9

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Thrombocytopenia associated with linezolid therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

TAK-599, a novel N-Phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Ceftaroline: a cephalosporin with expanded Gram-positive activity

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ253

21 January 2018

Identifiers

10.1093/JAC/DKQ253

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42790618&oldid=2143964595"